Home > Insider Trading > Filing (0001127602-10-011602)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310142	Sensient Technologies Corp	SXT	Industrial Organic Chemicals (2860)	390561070

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1199081	P Kenneth Manning	777 East Wisconsin Avenue Milwaukee WI 53202	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-04-20	60,000	$23.19	309,398	No	4	M	Direct
Common Stock	Disposition	2010-04-20	60,000	$31.15	249,398	No	4	S	Direct
Common Stock	Disposition	2010-04-20	21,575	$31.16	227,823	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2010-04-20	60,000	$0.00	60,000	$23.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
86,604	2003-12-09	2012-12-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,793	Indirect	ESOP
Common Stock	16,371	Indirect	Savings Plan
Common Stock	2,000	Indirect	Spouse
Common Stock	51,383	Indirect	Supplemental Benefit Plan

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$23.00	2005-12-06	2014-12-06	28,396	28,396	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-12-06	28,396	28,396	Direct

Footnotes

Exercise of in-the-money stock option that would otherwise expire on 12/9/2012, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $30.90 to $31.71. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents shares held in Issuer's ESOP as of the end of the month immediately preceding this filing.
Represents shares held in Issuer's Savings Plan as of the end of the month immediately preceding this filing.
Represents shares held in Issuer's Supplemental Benefit Plan as of the most recent statement date.
Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.